OncoMethylome granted Exact Sciences exclusive development and commercialization rights to up to two DNA methylation biomarkers for use in stool-based detection of colorectal cancer

OncoMethylome Sciences S.A.

Belgium / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Exact Sciences Corp.

U.S. / Small-Cap Biopharma (<$1 billion)

$166.8m on 07/30/2010 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced